<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04946578</url>
  </required_header>
  <id_info>
    <org_study_id>Sport and microbiota</org_study_id>
    <nct_id>NCT04946578</nct_id>
  </id_info>
  <brief_title>The Effect of Prebiotics on Endurance Performance</brief_title>
  <official_title>Modulation of the Intestinal Microbiome, and Its Effects on Endurance Exercise Capacity in Moderately Trained Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the effect of a six-week period personalised food&#xD;
      intervention with prebiotic supplementation on intense exercise performance in healthy,&#xD;
      recreationally active adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study conforms to a randomized, single-blinded, placebo-controlled parallel study design.&#xD;
&#xD;
      a prebiotic supplement will be selected based on a participants gut microbiota. 1 sachet of&#xD;
      prebiotic or placebo will be given twice a day over a period of 6 weeks.&#xD;
&#xD;
      Before the start of the study, a VO2max test will be performed. Subjects will bring faecal&#xD;
      samples which is collected at home. A time to exhaustion of approximately 80% of their VO2max&#xD;
      will be performed at baseline and after the 6 weeks intervention period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 24, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 23, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study conforms to a randomized, single-blinded, placebo-controlled parallel study design.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Exhaustion</measure>
    <time_frame>From baseline to end of the study (up to max 45 days)</time_frame>
    <description>Time on cycle ergometer until exhaustion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gut microbiota composition</measure>
    <time_frame>From baseline to end of the study (up to max 45 days)</time_frame>
    <description>Composition of the gut microbiota by faecal sample analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma short chain fatty acids</measure>
    <time_frame>From baseline to end of the study (up to max 45 days)</time_frame>
    <description>Short chain fatty acids in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood glucose</measure>
    <time_frame>From baseline to end of the study (up to max 45 days)</time_frame>
    <description>Fasted blood glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>From baseline to end of the study (up to max 45 days)</time_frame>
    <description>Fasted insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intestinal permeability by sugar test</measure>
    <time_frame>From baseline to end of the study (up to max 45 days)</time_frame>
    <description>Intestinal permeability measured by a sugar drink test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Microtia</condition>
  <arm_group>
    <arm_group_label>Prebiotic intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prebiotic supplementation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Maltodextrin</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Prebiotic</intervention_name>
    <description>6 weeks of prebiotic supplementation twice a day</description>
    <arm_group_label>Prebiotic intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>6 weeks of maltodextrin supplementation twice a day</description>
    <arm_group_label>Placebo control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female 18 - 40 y&#xD;
&#xD;
          -  BMI range 18.5 - 25 kg/m2&#xD;
&#xD;
          -  Recreational active (performing non-competitive physical endurance exercise at least&#xD;
             two times per week with a minimum duration of 60 minutes per exercise bout)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Performing regular resistance training (3+ times per week, carrying out progressive&#xD;
             overload training)&#xD;
&#xD;
          -  Subject following an overly imbalanced or restrictive diet as per nutritional advice&#xD;
&#xD;
          -  Participants who received antibiotics in the 90 days prior to the start of the study&#xD;
&#xD;
          -  Self-admitted lactose intolerance&#xD;
&#xD;
          -  Administration of probiotic or prebiotic supplements in the 14 days prior to the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Freddy Troost, Dr.</last_name>
    <phone>+31(0)43 3884296</phone>
    <email>f.troost@maastrichtuniversity.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maastricht University</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 5, 2021</study_first_submitted>
  <study_first_submitted_qc>June 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2021</study_first_posted>
  <last_update_submitted>June 23, 2021</last_update_submitted>
  <last_update_submitted_qc>June 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maastricht University</investigator_affiliation>
    <investigator_full_name>Fred Troost</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Microtia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

